Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia. [electronic resource]
Producer: 20181019Description: 274-282 p. digitalISSN:- 1347-8648
- Animals
- Atrial Fibrillation -- etiology
- Cells, Cultured
- Endothelial Cells -- pathology
- Factor Xa Inhibitors -- pharmacology
- Fibrosis -- prevention & control
- Hypoxia -- complications
- MAP Kinase Signaling System -- drug effects
- Male
- Mice, Inbred C57BL
- Molecular Targeted Therapy
- Myocardium -- pathology
- NF-kappa B -- metabolism
- Oligopeptides -- pharmacology
- Oxidative Stress -- drug effects
- Receptor, PAR-2 -- antagonists & inhibitors
- Rivaroxaban -- pharmacology
- Sleep Apnea, Obstructive -- complications
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.